NADA has been observed to reduce prostate carcinoma cell proliferation via nuclear factor (NF)-κB/cyclin D- and cyclin E-dependent pathways [35], and it inhibited the invasion of prostate cancer cells by downregulation of protein kinase A (PKA) activity [36]. Here, CCNE1 is linked to prostate carcinoma.